MOLIVIA

Serial Number 86512273
606

Registration Progress

Application Filed
Jan 23, 2015
Under Examination
Sep 1, 2015
Approved for Publication
Jul 7, 2015
Published for Opposition
Jul 7, 2015
Registered

Trademark Image

MOLIVIA

Basic Information

Serial Number
86512273
Filing Date
January 23, 2015
Published for Opposition
July 7, 2015
Abandonment Date
April 4, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 4, 2016
Classes
005

Rights Holder

Synergy Pharmaceuticals Inc.

03
Address
420 Lexington Avenue, Suite 2012
New York, NY 10170

Ownership History

Synergy Pharmaceuticals Inc.

Original Applicant
03
New York, NY

Synergy Pharmaceuticals Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Janet L. Cullum

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

16 events
Date Code Type Description Documents
Apr 4, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 4, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Sep 1, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 7, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 7, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 17, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 2, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 1, 2015 ALIE A ASSIGNED TO LIE Loading...
May 5, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 4, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 4, 2015 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 4, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 4, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 28, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 4, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 27, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of gastrointestinal swelling, bloating, pain, inflammation, and diarrhea; pharmaceutical preparations for use in the treatment of constipation, irritable bowel syndrome, colitis, gastrointestinal disorders and gastrointestinal diseases; gastrointestinal hormone analogue preparations for medical purposes; laxatives; antiemetics; anti-diarrheal and anti-inflammatory pharmaceutical preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005